e-learning resources

ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Pulmonary drug and devices delivery

Poster Discussion
Chairs: O. Usmani (London, United Kingdom), F. Lavorini (FIRENZE, Italy)

Download all media

Download all media

Formoterol Aerolizer inhaler technique in patients with Asthma and COPD M. Balzan (Tal Qroqq, Malta)
Safety, Tolerability (S&T) and Pharmacokinetics (PK) of Single and Repeat Inhaled Doses of Phosphoinositide-3-Kinase Delta Inhibitor (PI3Kd) GSK2269557, Delivered via the ELLIPTATM Device to Healthy Subjects in a Phase I Trial, Including Charcoal Block. R. Wilson (London, United Kingdom)
Extrafine compared to non-extrafine particle ICS in smokers and ex-smokers with asthma C. Cox (Groningen, Netherlands)
Lung deposition of fluticasone propionate/formoterol administered via a breath-triggered inhaler P. Dalvi (CAMBRIDGE, United Kingdom)
Relative pulmonary bioavailability (BA) of fluticasone propionate/formoterol (FP/FORM) via pressurised metered-dose inhaler (pMDI) and a novel breath-triggered inhaler (BTI) T. Overend (Cambridge, United Kingdom)
Plume spray force of three HFA-propelled ICS/LABA combination inhalers J. Marshall (Cambridge, United Kingdom)
Assessment of the technique in different inhalation devices and investigating the factors associated with inhaler misuse in COPD patients C. Yang (Douliu, Taiwan)
Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles W. Vos (Heist-op-den-Berg, Belgium)
In vitro evaluation of aerosolized delivery of various medications during mechanical ventilation H. Lin (Taoyuan , Taiwan)
Impact of asthmatic patient satisfaction with the inhaler upon adherence, disease control and quality of life. Results of the ASCONA study F. Gutierrez Pereyra (BARCELONA, Spain)
Pressurised metered dose inhalers (pMDIs) with integrated flow rate guidance. M. Sanders (Harlow, Essex, United Kingdom)
Compared Aerosol Drug Delivery Efficacy of Two Types Nebulizer in Adult Mechanical Ventilator Y. Kao (Taoyuan, Taiwan)
Pharmacokinetics (PK) of a single dose AZD7594 administered intravenously (IV), orally, and inhaled via two dry powder inhalers (DPI) and a pressurized metered-dose inhaler (pMDI) Y. Chen (Waltham, United States of America)
Tools with inhalation technique feedback to improve and maintain pMDI use in asthma patients W. Ammari (Amman, Jordan)
CHF5993 pMDI (extrafine Beclometasone Dipropionate:BDP, Formoterol Fumarate:FF, Glycopyrronium Bromide:GB) reduces Clinically Important Deteriorations (CID) in COPD: post-hoc analysis of TRILOGY study. M. Scuri (PARMA, PR, Italy)
Control of asthma, adherence to inhaled therapy and usefulness of the Test of Adherence to Inhalers (TAI). Results of the ASCONA study F. Gutierrez Pereyra (BARCELONA, Spain)
Never enough training – patient mistakes during inhalation therapy are repetitive. K. Luczak (Warszawa, Poland)
Impact of short training of inhalation technique on the course of asthma and COPD M. Dabrowska (Warszawa, Poland)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.